Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia

Wendelien Zeijlemaker,Angèle Kelder,Y J M Oussoren-Brockhoff,Willemijn J. Scholten,Alexander N. Snel,Dennis Veldhuizen,Jacqueline Cloos,G.J. Ossenkoppele,G J Schuurhuis

Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia

2016

Wendelien Zeijlemaker
Angèle Kelder
Y J M Oussoren-Brockhoff
Willemijn J. Scholten
Alexander N. Snel
Dennis Veldhuizen
Jacqueline Cloos
G.J. Ossenkoppele
G J Schuurhuis

Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia

Keywords:

Minimal residual disease
Bone marrow
Myeloid leukemia
Case-control study
Immunophenotyping
Consolidation Chemotherapy
Survival analysis
Biomarker (medicine)
Pathology
Medicine
Internal medicine
Cancer research
CD34
Cumulative incidence
Gastroenterology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations